Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diphtheria immunity in Flanders

C Matheï1, P Van Damme, P Bruynseels

  • 1Department of Epidemiology and Community Medicine, University of Antwerp, Belgium.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|November 14, 1997
PubMed
Summary

A diphtheria immunity survey found 43% of Flemish adults are protected, but many remain susceptible. This highlights the critical need for adult booster immunizations to maintain public health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Pseudomonas aeruginosa carriage on intensive care unit-acquired pneumonia: a European multicentre prospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2024
Same author

Long-term effects of ciprofloxacin treatment on the gastrointestinal and oropharyngeal microbiome are more pronounced after longer antibiotic courses.

International journal of antimicrobial agents·2024
Same author

Antibiotic use among surgical inpatients at a tertiary health facility: a case for a standardized protocol for presumptive antimicrobial therapy in the developing world.

Infection prevention in practice·2021
Same author

Uptake of hepatitis C virus screening and treatment in persons under opioid substitution therapy between 2008 and 2013 in Belgium.

Acta gastro-enterologica Belgica·2021
Same author

Phenotypic and molecular characterizations of carbapenem-resistant Acinetobacter baumannii isolates collected within the EURECA study.

International journal of antimicrobial agents·2021
Same author

Emergence of ST654 Pseudomonas aeruginosa co-harbouring bla<sub>NDM-1</sub> and bla<sub>GES-5</sub> in novel class I integron In1884 from Bulgaria.

Journal of global antimicrobial resistance·2020

Area of Science:

  • Immunology
  • Public Health
  • Epidemiology

Background:

  • Diphtheria remains a public health concern globally.
  • Assessing population immunity is crucial for targeted vaccination strategies.
  • Previous diphtheria immunity data for the Flemish population is limited.

Purpose of the Study:

  • To determine the current level of diphtheria immunity in the Flemish population.
  • To identify age groups with inadequate diphtheria protection.
  • To inform public health policy regarding diphtheria booster immunizations.

Main Methods:

  • A serological survey was conducted on a representative sample of 1679 individuals from the Flemish population.
  • Serum diphtheria antitoxin concentrations were measured using a Vero cell culture toxin neutralization assay.

Related Experiment Videos

  • The study included participants across all age groups from 0 to 100 years.
  • Main Results:

    • 43% of the Flemish population demonstrated protective immunity against diphtheria (antitoxin titre ≥ 0.1 IU/ml).
    • 32% of individuals were found to be susceptible (antitoxin titre < 0.01 IU/ml).
    • A significant age-related increase in susceptibility was observed, particularly in adults aged 35-54 years.

    Conclusions:

    • A substantial portion of the Flemish population lacks adequate diphtheria immunity.
    • Adults, especially those aged 35-54, are at higher risk of diphtheria.
    • Booster immunization programs for adults are strongly recommended to enhance population-level protection against diphtheria.